טוען...
Ectokinases as novel cancer markers and drug targets in cancer therapy
While small-molecule kinase inhibitors became the most prominent anticancer drugs, novel combinatorial strategies need to be developed as the fight against cancer is not yet won. We review emerging literature showing that the release of several ectokinases is significantly upregulated in body fluids...
שמור ב:
| הוצא לאור ב: | Cancer Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BlackWell Publishing Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4380966/ https://ncbi.nlm.nih.gov/pubmed/25504773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.368 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|